Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fanny Rolet"'
Autor:
Wail Sabbani, Bernard Orsal, Luc P.R. Bidel, Laurent Urban, Christian Jay-Allemand, Fanny Rolet
Publikováno v:
2021 4th International Conference on Bio-Engineering for Smart Technologies (BioSMART).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc80e5c47ea4439a84b9f945c3984083
https://doi.org/10.1109/biosmart54244.2021.9677763
https://doi.org/10.1109/biosmart54244.2021.9677763
Publikováno v:
Clinica Chimica Acta, 424, pp. 222-30
Clinica Chimica Acta, 424, 222-30
El Messaoudi, S, Rolet, F, Mouliere, F & Thierry, A R 2013, ' Circulating cell free DNA : Preanalytical considerations ', Clinica Chimica Acta, vol. 424, pp. 222-230 . https://doi.org/10.1016/j.cca.2013.05.022
Clinica Chimica Acta, 424, 222-30
El Messaoudi, S, Rolet, F, Mouliere, F & Thierry, A R 2013, ' Circulating cell free DNA : Preanalytical considerations ', Clinica Chimica Acta, vol. 424, pp. 222-230 . https://doi.org/10.1016/j.cca.2013.05.022
Item does not contain fulltext Despite the growing interest in circulating cell-free DNA (ccfDNA) analysis in various clinical fields, especially oncology and prenatal diagnosis, few studies on sample handling have been reported and no analytical con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684a6e0e8c0126f4faa408a580501141
http://www.scopus.com/inward/record.url?scp=84880375472&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=84880375472&partnerID=8YFLogxK
Autor:
Bruno Robert, Michelle Nouaille, Virginie Loriot, Frédéric Bibeau, Safia El Messaoudi, Denis Pezet, Maguy Del Rio, Anne Sophie Jarrousse, Pierre-Jean Lamy, Alain R. Thierry, Céline Gongora, Marc Ychou, Fanny Rolet, Evelyne Lopez-Crapez, Muriel Mathonnet, Caroline Mollevi, Franck Molina, Brigitte Gillet, Pierre Déchelotte, Florent Mouliere
Publikováno v:
Nature Medicine
Nature Medicine, Nature Publishing Group, 2014, 20 (4), pp.430-435. ⟨10.1038/nm.3511⟩
Nature Medicine, 20(4), 430-435. Nature Publishing Group
Nature Medicine, Nature Publishing Group, 2014, 20, pp.430--5. ⟨10.1038/nm.3511⟩
Thierry, A R, Mouliere, F, El Messaoudi, S, Mollevi, C, Lopez-Crapez, E, Rolet, F, Gillet, B, Gongora, C, Dechelotte, P, Robert, B, Del Rio, M, Lamy, P J, Bibeau, F, Nouaille, M, Loriot, V, Jarrousse, A S, Molina, F, Mathonnet, M, Pezet, D & Ychou, M 2014, ' Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA ', Nature Medicine, vol. 20, no. 4, pp. 430-435 . https://doi.org/10.1038/nm.3511
Nature Medicine, 2014, 20 (4), pp.430-435. ⟨10.1038/nm.3511⟩
Nature Medicine, Nature Publishing Group, 2014, 20 (4), pp.430-435. ⟨10.1038/nm.3511⟩
Nature Medicine, 20(4), 430-435. Nature Publishing Group
Nature Medicine, Nature Publishing Group, 2014, 20, pp.430--5. ⟨10.1038/nm.3511⟩
Thierry, A R, Mouliere, F, El Messaoudi, S, Mollevi, C, Lopez-Crapez, E, Rolet, F, Gillet, B, Gongora, C, Dechelotte, P, Robert, B, Del Rio, M, Lamy, P J, Bibeau, F, Nouaille, M, Loriot, V, Jarrousse, A S, Molina, F, Mathonnet, M, Pezet, D & Ychou, M 2014, ' Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA ', Nature Medicine, vol. 20, no. 4, pp. 430-435 . https://doi.org/10.1038/nm.3511
Nature Medicine, 2014, 20 (4), pp.430-435. ⟨10.1038/nm.3511⟩
Assessment of KRAS status is mandatory in patients with metastatic colorectal cancer (mCRC) before applying targeted therapy. We describe here a blinded prospective study to compare KRAS and BRAF mutation status data obtained from the analysis of tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93348287c91fc43a20420d12d4e6fc72
https://hal.archives-ouvertes.fr/hal-02362372
https://hal.archives-ouvertes.fr/hal-02362372
Autor:
Florent Mouliere, Denis Pezet, Franck Molina, M. del Rio, Muriel Mathonnet, Alain R. Thierry, Evelyne Lopez-Crapez, A.S. Guedj, M. Ychou, Pierre-Jean Lamy, Fanny Rolet, S. El Messaoudi, Céline Gongora
Publikováno v:
Annals of Oncology. 23:v36-v37
Circulating DNA (ctDNA) analysis constitutes a hopeful approach to provide a non-invasive test potentially allowing diagnosis, prognosis, theranostics, therapeutic monitoring and follow-up in cancer patients. We studied tumour-derived ctDNA by an ori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eb6daf47694a6716169ad74c7c64c4e
https://doi.org/10.1016/s0923-7534(20)31365-x
https://doi.org/10.1016/s0923-7534(20)31365-x
Autor:
Franck Molina, Fanny Rolet, Muriel Mathonnet, Pierre-Jean Lamy, Alain R. Thierry, Denis Pezet, Florent Mouliere, Caroline Mollevi, Evelyne Lopez-Crapez, Maguy Del Rio, Frédéric Bibeau, Céline Gongora, Marc Ychou, Virginie Loriot, Safia El Messaoudi
Publikováno v:
Journal of Clinical Oncology. 30:10505-10505
10505 Background: We developed a specific method for circulating cell-free DNA (ctDNA) enabling the detection of point mutations. CtDNA exists at high level in patients with different types of cancer, and presents great potential in regards, in parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55d13371bfcf47e47d204a3926fdb3b5
https://doi.org/10.1200/jco.2012.30.15_suppl.10505
https://doi.org/10.1200/jco.2012.30.15_suppl.10505